CYTK vs HRL · rev $28.6M vs P/E 29, rev $8.96B
Cytokinetics Inc (CYTK) versus Hormel Foods Corporation (HRL) — a side-by-side from cached financials, not a winner call.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
Hormel Foods Corporation (HRL) is a packaged foods company listed on NYSE.
Latest reported CYTK revenue for 2026-06-30 was $28.6M. Net income was -$198.8M. Revenue was up 47.9% from 2026-03-31 to 2026-06-30. CYTK currently screens at market cap $4.05B.
Latest reported HRL revenue for 2026-07-26 was $8.96B. Net income was $398.8M. Revenue was up 49.4% from 2026-04-26 to 2026-07-26. HRL currently screens at market cap $13.39B and trailing P/E 28.6.
CYTK currently screens at market cap $4.05B. HRL currently screens at market cap $13.39B and trailing P/E 28.6.
Not investment advice. Open the CYTK and HRL stock pages for the full models.
Not investment advice.